Culverwell Anthony James
SEC insider (Form 3/4/5 filer). CIK 0001693548. Director at Quoin Pharmaceuticals, Ltd. (QNRX). 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in ASHBURN, VA.
Companies Culverwell Anthony James has filed insider reports for
- Quoin Pharmaceuticals, Ltd. (QNRX): Director
Culverwell Anthony James
CIK: 0001693548
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Quoin Pharmaceuticals, Ltd.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 31, 2026QNRX
Quoin Pharmaceuticals, Ltd.
PurchaseDirect6.1K shares at avg. $4.88$30K - Aug 27, 2026QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirect31.4K shares at avg. $5.15$161K - Feb 4, 2026QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
21.7K shares- - Aug 21, 2025QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
13.7K shares- - May 29, 2025QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
7.8K shares- - Dec 23, 2024QNRX
Quoin Pharmaceuticals, Ltd.
PurchaseDirect100K shares at avg. $0.45$45K - Dec 9, 2024QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
50.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | Purchase | 6,146 | $4.88 | $29,992 | Direct |
| Aug 27, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | Award | 31,352 | $5.15 | $161,463 | Direct |
| Feb 4, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 21,709 | - | - | Direct |
| Aug 21, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 13,682 | - | - | Direct |
| May 29, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 7,760 | - | - | Direct |
| Dec 23, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Purchase | 100,000 | $0.45 | $45,000 | Direct |
| Dec 9, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 50,714 | - | - | Direct |
1-7 of 7 transactions